261 related articles for article (PubMed ID: 10209002)
21. Kininase II-type enzymes. Their putative role in muscle energy metabolism.
Dragović T; Minshall R; Jackman HL; Wang LX; Erdös EG
Diabetes; 1996 Jan; 45 Suppl 1():S34-7. PubMed ID: 8529798
[TBL] [Abstract][Full Text] [Related]
22. Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction.
Blais C; Lapointe N; Rouleau JL; Clément R; Gervais N; Geadah D; Adam A
Peptides; 2001 Jun; 22(6):953-62. PubMed ID: 11390026
[TBL] [Abstract][Full Text] [Related]
23. Neutral endopeptidase and angiotensin-converting enzyme inhibitors increase nitric oxide production in isolated canine coronary microvessels by a kinin-dependent mechanism.
Zhang X; Nasjletti A; Xu X; Hintze TH
J Cardiovasc Pharmacol; 1998 Apr; 31(4):623-9. PubMed ID: 9554814
[TBL] [Abstract][Full Text] [Related]
24. Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed.
Dumoulin MJ; Adam A; Rouleau JL; Lamontagne D
J Cardiovasc Pharmacol; 2001 Apr; 37(4):359-66. PubMed ID: 11300648
[TBL] [Abstract][Full Text] [Related]
25. Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin-converting enzyme and other peptidases.
Adam A; Leclair P; Montpas N; Koumbadinga GA; Bachelard H; Marceau F
Neuropeptides; 2010 Apr; 44(2):69-75. PubMed ID: 19836835
[TBL] [Abstract][Full Text] [Related]
26. Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.
Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U
Br J Pharmacol; 2006 Jul; 148(6):825-32. PubMed ID: 16770319
[TBL] [Abstract][Full Text] [Related]
27. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
Walther T; Siems WE; Hauke D; Spillmann F; Dendorfer A; Krause W; Schultheiss HP; Tschöpe C
FASEB J; 2002 Aug; 16(10):1237-41. PubMed ID: 12153991
[TBL] [Abstract][Full Text] [Related]
28. Combinatorial inhibition of Angiotensin converting enzyme, Neutral endopeptidase and Aminopeptidase N by N-methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension.
Savitha MN; Suvilesh KN; Siddesha JM; Milan Gowda MD; Choudhury M; Velmurugan D; Umashankar M; Vishwanath BS
Peptides; 2020 Jan; 123():170180. PubMed ID: 31715212
[TBL] [Abstract][Full Text] [Related]
29. The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.
Dumoulin MJ; Adam A; Burnett J; Heublein D; Yamaguchi N; Lamontagne D
Can J Physiol Pharmacol; 2005 Feb; 83(2):166-73. PubMed ID: 15791290
[TBL] [Abstract][Full Text] [Related]
30. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
Mellin V; Jeng AY; Monteil C; Renet S; Henry JP; Thuillez C; Mulder P
J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
[TBL] [Abstract][Full Text] [Related]
31. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
[TBL] [Abstract][Full Text] [Related]
32. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart.
Dendorfer A; Wolfrum S; Wellhöner P; Korsman K; Dominiak P
Br J Pharmacol; 1997 Nov; 122(6):1179-87. PubMed ID: 9401784
[TBL] [Abstract][Full Text] [Related]
33. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
Pelorosso FG; Halperin AV; Palma AM; Nowak W; Errasti AE; Rothlin RP
J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
[TBL] [Abstract][Full Text] [Related]
34. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
35. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
Linz W; Wiemer G; Schölkens BA
Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin and bradykinin metabolism by peptidases identified in cultured human skeletal muscle myocytes and fibroblasts.
Vaghy PL; Russell JS; Lantry LE; Stephens RE; Ward PE
Peptides; 1995; 16(8):1367-73. PubMed ID: 8745045
[TBL] [Abstract][Full Text] [Related]
37. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
38. Possible involvement of placental proteases in bradykinin (BK) degradation.
Kuno N; Mizutani S; Ohno Y; Goto K; Itakura A; Kondo I; Kurauchi O; Kikkawa F; Tomoda Y
Reprod Fertil Dev; 1997; 9(6):633-9. PubMed ID: 9551668
[TBL] [Abstract][Full Text] [Related]
39. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
Nolly H; Miatello R; Damiani MT; Abate CD
Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts.
Kichuk MR; Zhang X; Oz M; Michler R; Kaley G; Nasjletti A; Hintze TH
Am J Cardiol; 1997 Aug; 80(3A):137A-142A. PubMed ID: 9293967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
